Featured Articles

Features
Pharmaceuticals are not only regulated by traditional pharmaceutical legislation but are also increasingly influenced by related environmental and stewardship laws. Extended producer responsibility (EPR) is reshaping the pharmaceutical industry with regulatory burdens, challenges, and strategic opportunities.
Features

Sustainability principles can be effectively integrated into commissioning and qualification (C&Q) projects to support environmental goals without compromising compliance, quality, or patient safety. By positioning C&Q as both a verification tool and an enabler of sustainable intent, this article outlines a practical path for the pharmaceutical sector to enhance operational efficiency,...

Features

The development of platform drug delivery devices for combination products offers a transformative approach to drug delivery by enabling the reuse of device data across multiple drug and device combinations.

Technical
Containment systems are essential in pharmaceutical manufacturing, ensuring product quality and protecting worker safety. They prevent cross-contamination, reduce occupational exposure to potent compounds, and support compliance with global Good Manufacturing Practice (GMP) standards. As manufacturing evolves, robust and adaptable containment strategies are increasingly vital for maintaining...
InTouch

Michelle Vuolo is currently Head of Quality at Tulip Interfaces, Inc., a platform developer that enables manufacturers of many industries to build digital content to manage their operations. Before joining Tulip, Michelle spent more than 24 years in the biopharmaceutical and medical devices industries in quality control (QC) laboratories, engineering technical support, quality assurance...

InTouch

Stephanie Stärkle is a project engineer at VTU Engineering in Switzerland, where she leads engineering projects from concept to execution in GMP-regulated environments including cost estimation, equipment design and specification, deadline management, and coordination with cross-functional stakeholders such as vendors, quality assurance, operations, and qualification. She holds a bachelor’s...

InTouch
There are everyday examples of climate impacts—an unexpected storm that creates flash flooding, extremely high temperatures for more days than normal, and longer droughts. According to the World Health Organization, if the climate continues changing at the same rate, it is expected to cause approximately 250,000 additional deaths per year, with direct damage costs of between US $2–$4 billion.
Insights

When I began my career as an engineer in a major pharmaceutical company, I worked in an engineering department filled with highly experienced senior engineers. I admired their depth of knowledge and the way they had accumulated a wealth of practical information over decades. Their grasp of systems, processes, and equipment was impressive and humbling. I found myself anxious to build that same...

Online Exclusives
Over the past decade, Advanced Therapy Medicinal Products (ATMPs) have introduced a significant shift to pharmaceutical manufacturing, introducing a new generation of personalized medicines that demonstrate promising results for diseases with few or no treatment options. In the United States, approximately 34,000 patients have received CAR T-cell therapies since 2024. With 17 authorized products...
Features

Advancements in technology—such as process intensification, continuous manufacturing, and 3D printing—are enabling transportable and point-of-care (PoC) medicines manufacturing, especially with the rise of personalized medicine. Modular, small-scale production systems are particularly well-suited for cell and gene therapies and other advanced therapy medicinal products (ATMPs) designed for...

Features

Simplified approaches that enable changes to analytical procedures over their lifecycle are needed to allow continual improvements and adaptations due to technological obsolescence and other challenges. This article reflects on the positive impact that the recent ICH Q14 guidance can have on facilitating these changes. Five examples are provided that are based on scenarios in which analytical...

Features

The International Council for Harmonisation (ICH) Q2(R2) and Q14 guidelines, finalized in late 2023, outline strategies for analytical procedure development, validation, and lifecycle management. As global implementation progresses, ISPE’s PQLI® Analytical Method Strategy Team surveyed industry stakeholders in mid-2024 to assess readiness, identify opportunities, and highlight areas...

Features

In April 2023, ISPE launched a survey to understand the sources of barriers to technological innovation within the pharmaceutical industry. This survey is part of an expansive and significant initiative by ISPE, Enabling Global Pharma Innovation: Delivering for Patients, which aims to promote consistent and harmonized interpretation and implementation of guidelines issued by the International...

Features

Defining requirements for calibration and routine testing of weighing equipment in the laboratory and production remains a complex endeavor for pharmaceutical companies. Applying sound, risk-based metrological strategies across the entire pharmaceutical value chain will help manufacturers ensure compliance, consumer safety, and commercial success.

Features

The United States Pharmacopeia (USP) Packaging and Distribution Expert Committee approved chapters 665 and 1665 in 2024. These chapters establish clear and general guidelines for the use of plastic materials in process equipment used within the pharmaceutical and biotechnology industries. Their publication has raised new questions regarding the role of polymeric materials in manufacturing...

Features

The increasing digitalization of the pharmaceutical and medical device industry has created novel cybersecurity challenges, particularly with the rapid advancement of artificial intelligence (AI) technologies. This article examines the dual nature of AI as both a potential threat vector and a powerful defensive tool.

Features

The move to digital transformation represents a true paradigm shift in manufacturing, enabling organizations to leverage advanced technologies such as the Industrial Internet of Things (IIoT), cloud computing, and artificial intelligence (AI) to ensure compliance and secure a competitive advantage. This article presents a working definition of digital transformation, the components involved in...

Features

Pharmaceutical companies can use digital maturity assessments to address the challenges of upgrading brownfield facilities and implementing digital transformation improvements. Enabled by stakeholder workshops, these assessments can rapidly produce concrete plans and priorities to guide a facility’s development over the next three to five years—delivering business value and laying the...

Features
The complex transformation toward Pharma 4.0™ requires comprehensive skill management. This case study builds on a previously presented framework and follows the fictional company NewCo as it tackles the challenge of developing a future-ready workforce during a plant expansion project. Guided by the framework, NewCo first establishes skill management governance and a cross-functional team. It...
Features

Pharma 4.0™ is a reference framework tailored to the pharmaceutical industry, guiding its digital transformation. Although many of today’s processes generate sufficient data to enable advanced use cases, structured guidance for transformation is often lacking. To address this, the ISPE Pharma 4.0™ Subcommittee on Process Data Maps and Critical Thinking has introduced an approach to help...

Features

The often-overlooked function of chemistry, manufacturing, and controls (CMC) holds tremendous potential to reshape the landscape of drug development. By embracing innovation and rethinking traditional approaches, CMC has the rare opportunity to drive transformative changes that could significantly accelerate the journey from initial concept to a fully realized therapy. This offers the...

Explore

White Paper
This whitepaper provides principles and practical expectations for manufacturing operations within the scope of GMP Annex 1, focusing on four areas: environmental monitoring and control; aseptic process validation; equipment and facility design; and personnel practices. Each subject area was drafted as an individual chapter to the whitepaper by multicompany and multidisciplinary teams with...
White Paper
The life science validation sector is evolving with a focus on risk-based methodologies and increased access to digital data, driving innovation. The rise of Digital Validation Tools (DVTs) reflects the industry's emphasis on data integrity and principles of Pharma 4.0 and Validation 4.0. These advancements streamline monitoring and provide real-time insights into validated statuses through...
White Paper

Currently, there is no single guidance document providing a comprehensive roadmap for executing digital validation. While elements from ISPE GAMP® Guides Series and the ISPE Baseline® Guide: Volume 8 – Pharma 4.0™, apply to digital validation, there is no consolidated resource addressing common questions. The authors of this Concept Paper therefore advocate for the development of a Good...

Latest Articles

Online Exclusives

This article defines what constitutes a holistic control strategy in pharmaceutical development and manufacturing. It highlights the limitations of traditional, siloed approaches and demonstrates the added value of integrating these approaches across multiple dimensions. By identifying key gaps and proposing technological enablers, the article outlines a path toward a more comprehensive,...

iSpeak Blog

P&ID walk-downs are a critical activity during commissioning and qualification (C&Q) turnover, ensuring that physical installations align with the design intent. Traditionally, this process relies on manual checks using printed drawings, which is labor-intensive and prone to human error. Although digital platforms exist across design, engineering, construction and turnover...

iSpeak Blog

In 2020, CSL initiated a benchmarking activity with a small group of peer companies identified through ISPE to explore creation and maturation of Asset Management programs at each company. The initial sessions were a success, covering topics such as Asset Condition Evaluations and Asset Management Governance. CSL was keen to continue the conversations and gather more insights on certain...

iSpeak Blog

ISPE has once again assembled the most comprehensive industry conference on aseptic manufacturing that all should attend. The planning committee began their efforts within days of last year’s outstanding conference, with this year’s building upon the learning of last year. The speakers at this year’s conference are shaping the future of aseptic processing and sterile manufacturing. The

iSpeak Blog

Pharmaceutical companies have changed their operational model to meet the growing demand for complex biopharmaceuticals. These changes have allowed the pharmaceutical industry to deliver more than just the most efficient and sustainable solutions. Beyond efficiency, the pharmaceutical industry has begun leveraging advanced technologies to reshape the drug discovery and development process...

iSpeak Blog

Two members of the International Society for Pharmaceutical Engineering (ISPE) participated in a recent workshop organized by the National Academies of Sciences, Engineering, and Medicine (NASEM). The event, titled Improving Resiliency in the U.S. Pharmaceutical Supply Chain Through Make-Buy-Invest Strategic Actions, was held on 22–23 October in Washington, D.C., USA, and via remote access....

iSpeak Blog

On 20–21 October 2025, ISPE’s Enabling Pharmaceutical Innovation initiative team partnered with Brazil’s National Health Surveillance Agency (ANVISA) to host a workshop focused on innovation and regulatory harmonization in Latin America. The event aimed to explore opportunities for industry to work together with ANVISA and other health authorities to reduce obstacles and encourage innovative...

iSpeak Blog
ISPE was founded in 1980 to create a collaborative space for life sciences professionals to connect, share knowledge, and innovate to advance the industry. Over 45 years, ISPE has evolved from an idea into a global community focused on knowledge advancement, raising the benchmark for industry standards, and inspiring excellence. ISPE guides industry practices, supports innovation, and fosters...
iSpeak Blog

Laboratories are among the most resource-intensive environments, consuming large amounts of energy, water, and chemicals while providing much needed healthcare solutions to the community. It is important that an organization’s focus on go green initiatives trickles down all the way to how the laboratories handle their reagents, consumables, their instruments, laboratory process while...

iSpeak Blog

Pharmaceutical manufacturing is at a turning point. For decades, large-scale centralized facilities have been the backbone of medicine production, but today’s healthcare landscape demands something different: flexibility and personalization. Patients need therapies that are accessible anywhere, tailored to individual needs, and produced with resiliency against shortages. Emerging models like...

iSpeak Blog

On the final day of the 2025 ISPE Annual Meeting & Expo, regulators and senior industry leaders convened for the Global Regulatory Town Hall—a long-standing and popular feature of the annual event. The discussion focused on the growing impact of digitalization and the increasing use of artificial intelligence (AI) by both regulators and industry. The session featured a mix of pre-prepared...

iSpeak Blog
The pharmaceutical industry has long recognized the value of process harmonization across global operations. For validation teams spanning multiple sites, the promise is compelling: standardized procedures that streamline reviews, accelerate training, and enable seamless movement of personnel across the organization. Yet many companies pursuing harmonization initiatives have discovered an...
iSpeak Blog

The 2025 ISPE Pharma 4.0™ Conference will take place 9–10 December in Barcelona, Spain, and virtually. In the videos and transcripts that follow, International Program Committee Member Line Lundsberg-Nielsen highlights several planned technical tracks and shares what she is most looking forward to at this year’s conference.

Current Issue

November / December 2025

In This Issue: We dive into sustainable practices in the pharma industry and effective ways to safely implement them.